Skip to main navigation Skip to search Skip to main content

Case series of topical 1.5% ruxolitinib cream for pediatric vitiligo

Research output: Contribution to journalArticlepeer-review

4 Scopus citations
Original languageEnglish
Pages (from-to)27-30
Number of pages4
JournalJAAD Case Reports
Volume54
DOIs
StatePublished - Dec 2024

Keywords

  • Janus kinase inhibitors
  • mixed vitiligo
  • nonsegmental vitiligo
  • pediatrics
  • repigmentation
  • ruxolitinib
  • segmental vitiligo
  • treatment

Cite this